Furthermore, combined serum IGF-1 levels and CP scores (IGF-CP score) more accurately predict 1 year mortality than CP or model for end-stage liver disease (MELD) scores alone in patients with decompensated cirrhosis (5). Here, IGF1 is linked to End Stage Liver Disease.